The interactions of neuromuscular blocking agents in man: the role of hexafluorenium.
D003650:Decamethonium Compounds / Q000494:pharmacology; D004336:Drug Antagonism; D004357:Drug Synergism; D004576:Electromyography; D005703:Gallamine Triethiodide / Q000494:pharmacology; D005730:Ganglionic Blockers / Q000494:pharmacology*; D006801:Humans; D009119:Muscle Contraction / Q000187:drug effects; D009132:Muscles / Q000494:pharmacology*; D009469:Neuromuscular Junction / Q000187:drug effects*; D000644:Quaternary Ammonium Compounds / Q000494:pharmacology*; D013390:Succinylcholine / Q000494:pharmacology; D014403:Tubocurarine / Q000494:pharmacology
D003650:Decamethonium Compounds; D005730:Ganglionic Blockers; D000644:Quaternary Ammonium Compounds; D013390:Succinylcholine; D005703:Gallamine Triethiodide; D014403:Tubocurarine